(Q33397525)

English

Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients (English)

1 reference

Europe PubMed Central

26 July 2017

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

Olivier Hermine

18

1 reference

Europe PubMed Central

26 July 2017

Bernard Bonnotte

object named as

Bernard Bonnotte

7

0 references

Charlotte Cunningham-Rundles

3

object named as

Charlotte Cunningham-Rundles

1 reference

Europe PubMed Central

26 July 2017

James Bruce Bussel

2

object named as

James B Bussel

1 reference

Europe PubMed Central

26 July 2017

Bertrand Godeau

17

object named as

Bertrand Godeau

1 reference

Europe PubMed Central

26 July 2017

14

object named as

Pascal Seve

1 reference

Europe PubMed Central

26 July 2017

author name string

Delphine Gobert

1

1 reference

Europe PubMed Central

26 July 2017

Lionel Galicier

4

1 reference

Europe PubMed Central

26 July 2017

Agnès Dechartres

5

1 reference

Europe PubMed Central

26 July 2017

Alice Berezne

6

1 reference

Europe PubMed Central

26 July 2017

Thierry DeRevel

8

1 reference

Europe PubMed Central

26 July 2017

Christophe Auzary

9

1 reference

Europe PubMed Central

26 July 2017

Roland Jaussaud

10

1 reference

Europe PubMed Central

26 July 2017

Claire Larroche

11

1 reference

Europe PubMed Central

26 July 2017

Alain LeQuellec

12

1 reference

Europe PubMed Central

26 July 2017

Marc Ruivard

13

1 reference

Europe PubMed Central

26 July 2017

Amar Smail

15

1 reference

Europe PubMed Central

26 July 2017

Jean-François Viallard

16

1 reference

Europe PubMed Central

26 July 2017

Marc Michel

19

1 reference

Europe PubMed Central

26 July 2017

language of work or name

0 references

publication date

8 October 2011

1 reference

Europe PubMed Central

26 July 2017

British Journal of Haematology

1 reference

Europe PubMed Central

26 July 2017

155

1 reference

Europe PubMed Central

26 July 2017

4

1 reference

Europe PubMed Central

26 July 2017

498-508

1 reference

Europe PubMed Central

26 July 2017

Effector and regulatory B cells: modulators of CD4+ T cell immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Infections in 252 patients with common variable immunodeficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Rituximab in the treatment of autoimmune haematological disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Response of refractory immune thrombocytopenic purpura in a patient with common variable immunodeficiency to treatment with rituximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

B-cell targeting in rheumatoid arthritis and other autoimmune diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Hematologic complications of primary immune deficiencies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

NIH conference. New insights into common variable immunodeficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428031

14 July 2018

Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08880.X

21 January 2018

Common variable immunodeficiency disorders: division into distinct clinical phenotypes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08880.X

21 January 2018

Common variable immunodeficiency: clinical and immunological features of 248 patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08880.X

21 January 2018

Autoimmune hemolytic anemia and common variable immunodeficiency: a case-control study of 18 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08880.X

21 January 2018

Common Variable Immunodeficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08880.X

21 January 2018

Successful anti-CD20 monoclonal antibody treatment of severe autoimmune hemolytic anemia due to warm reactive IgM autoantibody in a child with common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08880.X

21 January 2018

Autoimmunity in common variable immunodeficiency: Correlation with lymphocyte phenotype in the French DEFI study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08880.X

21 January 2018

Primary immunodeficiency diseases in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/21981575

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/21981575

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary immunodeficiency diseases in Norway

1 reference

https://pubmed.ncbi.nlm.nih.gov/21981575

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2141.2011.08880.X

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33397525&oldid=1805752363"